Matching-adjusted Indirect Comparison of Dermatology Life Quality Index 0/1 Response in Trials of Calcipotriol Plus Betamethasone Dipropionate Foam and Cream Formulations in Patients with Psoriasis

Acta Derm Venereol. 2024 Feb 8:104:adv12623. doi: 10.2340/actadv.v104.12623.

Authors

Ahmad Jalili¹, Henrik Thoning², Marie Y Jablonski Bernasconi², Kim Papp³

Affiliations

¹ Dermatology & Skin Care Clinic, Buochs, Switzerland.
² LEO Pharma A/S, Ballerup, Denmark.
³ Probity Medical Research, Waterloo, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. kapapp@actrials.ca.

No abstract available

MeSH terms

Betamethasone / adverse effects
Betamethasone / analogs & derivatives*
Calcitriol / analogs & derivatives*
Dermatologic Agents* / adverse effects
Dermatology*
Drug Combinations
Humans
Psoriasis* / diagnosis
Psoriasis* / drug therapy
Quality of Life
Treatment Outcome

Substances

betamethasone-17,21-dipropionate
calcipotriene
Betamethasone
Drug Combinations
Dermatologic Agents
Calcitriol